Search

everythinglearnresearchcommunity

for

Search:↓

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Dermatologists are important in helping transgender people with skin issues and physical changes during their transition.

Anabolic steroid users may face higher risk of severe COVID-19.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

Platelet-rich plasma is used for facial and hair treatments, showing benefits despite varying methods and limited research.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Defects in certain proteins cause major heart abnormalities during early development.

High DHA levels delay wound healing and worsen skin repair quality.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Prurigo pigmentosa mainly affects middle-aged White and Asian women, often linked to a ketogenic diet, and is best treated with oral antibiotics.

Dermatologists should use hair relaxers carefully to avoid hair and scalp damage, following specific guidelines for application and maintenance.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

The unique coat of lykoi cats is likely caused by new variants in the Hairless gene.

Long-term use of difluprednate eye drops in dogs can lead to hair loss and hormone imbalance.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

The KRTAP7-1 gene is very similar across different cattle and yak breeds and likely plays a role in hair strength and shape.

The document concludes that central centrifugal cicatricial alopecia (CCCA) should be considered in African American men with vertex hair loss and scalp symptoms, and that prompt diagnosis and treatment can slow disease progression.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

Androgenetic alopecia causes significant psychological distress, especially in women, and requires both medical and psychological support.

Lupus erythematosus can mimic alopecia areata, and trichoscopy is key for accurate diagnosis and better patient outcomes.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

The study found that Tourette Syndrome may be linked to certain immune system processes and synaptic signaling.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

A baby girl has a hair disorder called monilethrix, causing fragile hair that may improve over time.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Many dermatologists believe finasteride can cause sexual side effects and counsel patients about them.

Alopecia in lupus patients is often underdiagnosed and rarely biopsied.

Pregnant women with Systemic Lupus Erythematosus have a higher risk of blood clotting problems.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.